Abstract
Gene targeting in somatic cells represents a potentially powerful method for gene therapy, yet with the exception of pluripotent mouse embryonic stem (ES) cells, homologous recombination has not been reported for a well characterized, non–transformed mammalian cell. Applying a highly efficient strategy for targeting an integral membrane protein — the interferon γ receptor — in ES cells, we have used homologous recombination to target a non–transformed somatic cell, the mouse myoblast, and to compare targeting efficiencies in these two cell types. Gene–targeted myoblasts display the properties of normal cells including normal morphology, ability to differentiate in vitro, stable diploid karyotype, inability to form colonies in soft agar and lack of tumorigenicity in nude mice.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Camerini-Otero, R.D. & Kucherlapati, R. Right on target. New. Biol. 2, 337–341 (1990).
Patrusky, B. DNA on target. Mosaic 21, 44–52 (1990).
Waldman, A.S. Targeted homologous recombination in mammalian cells. Crit. Rev. Oncol. Hematol. 12, 49–64 (1992).
Capecchi, M.R. Altering the genome by homologous recombination. Science 244, 1288–1292 (1989).
Bradley, A., Hasty, P., Davis, A. & Ramirez-Solis, R. Modifying the mouse: design and desire. Biotechnology 10, 534–539 (1992).
Koller, B.H. & Smithies, O. Altering genes in animals by gene targeting. Annu. Rev. Immunol. 10, 705–730 (1992).
Jasin, M. & Berg, P. Homologous integration in mammalian cells without target gene selection. Genes Devl. 2, 1353–1363 (1988).
Sedivy, J.M. & Sharp, P.A. Positive genetic selection for gene disruption in mammalian cells by homologous recombination. Proc. natn. Acad. Sci. U.S.A. 86, 227–231 (1989).
Fell, H.P., Yamold, S., Hellstrom, I., Hellstrom, K.E. & Folger, K.R. Homologous recombination in hybridoma cells: heavy chain chimeric antibody produced by gene targeting. Proc. natn. Acad. Sci. U.S.A. 86, 8507–8511 (1989).
Charron, J., Malynn, B.A., Robertson, E.J., Goff, S.P. & Alt, F.W. High-frequency disruption of the N-myc gene in embryonic stem and pre-B cell lines by homologous recombination. Molec. Cell Biol. 10, 1799–1804 (1990).
Accili, D. & Taylor, S.I. Targeted inactivation of the insulin receptor gene in mouse 3T3-L1 fibroblasts via homologous recombination. Proc. natn. Acad. Sci. U.S.A. 88, 4708–4712 (1991).
Zheng, H. et al. Fidelity of targeted recombination in human fibroblasts and murine embryonic stem cells. Proc. natn. Acad. Sci. U.S.A. 88, 8067–8071 (1991).
Mauro, A. Satellite cells of skeletal muscle fibers. J. Biophys. Biochem. Cytol. 9, 493–495 (1961).
Partridge, T.A., Grounds, M. & Sloper, J.C. Evidence effusion between host and donor myoblasts in skeletal muscle grafts. Nature 273, 306–308 (1978).
Gussoni, E. et al. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature 356, 435–438 (1992).
Barr, E. & Leiden, J.M. Systemic delivery of recombinant proteins by genetically modified myoblasts. Science 254, 1507–1509 (1991).
Dhawan, J. et al. Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science 254, 1509–1512 (1991).
Partridge, T.A. Myoblast transfer: a possible therapy for inherited myopathies? Muscle Nerve. 14, 197–212 (1991).
Trinchieri, G. & Perussia, B. Immune interferon: a pleiotropic lymphokine with multiple effects. Immunol. Today 6, 131–136 (1985).
Pestka, S., Langer, J.A., Zoon, K.C. & Samuel, C.E. Interferons and their actions. A. Rev. Biochem. 56, 727–777 (1987).
Farrar, M.A. & Schreiber, R.D. The molecular cell biology of interferon-γ and its receptor. A Rev. Immunol. 11, 571–611 (1993).
Aguet, M., Dembic, Z. & Merlin, G. Molecular cloning and expression of the human interferon-γ receptor. Cell 55 273–280 (1988).
Rosa, F. & Fellous, M. The effect of gamma-interferon on MHC antigens. Immunol. Today 5, 261–262 (1984).
Doetschman, T., Maeda, N. & Smithies O. Targeted mutation of the Hprt gene in mouse embryonic stem cells. Proc. natn. Acad. Sci. U.S.A. 85, 8583–8587 (1988).
Schwartzberg, P.L., Robertson, E.J. & Goff, S.P. Targeted gene disruption of the endogenous c-abl locus by homologous recombination with DNA encoding a selectable fusion protein. Proc. natn. Acad. Sci. U.S.A. 87, 3210–3214 (1990).
te Riele, H., Maandag, E.R., Clarke, A., Hooper, M. & Berns, A. Consecutive inactivation of both alleles of the pim-1 proto-oncogene by homologous recombination in embryonic stem cells. Nature 348, 649–651 (1990).
Jeanotte, L., Ruiz, J.C. & Robertson, E.J. Low level of Hox1. 3 gene expression does not preclude the use of promoterless vectors to generate a targeted gene disruption. Molec. Cell Biol. 11, 5578–5585 (1991).
Hemmi, S. et al. Cloning of murine interferon γ receptor cDNA: expression in human cells mediates high-affinity binding but is not sufficient to confer sensitivity to murine interferon γ. Proc. natn. Acad. Sci. U.S.A. 86, 9901–9905 (1989).
Austin, H.A., Gurley, K. & Greenburg, G. Muscle satellite cells isolated from mice can be maintained in culture for long periods without the changes associated with cell transformation. In Vitro 29A, 105A (1993).
Farrar, M.A., Fernandez-Luna, J. & Schreiber, R.D. Identification of two regions within the cytoplasmic domain of the human interferon-gamma receptor required for function. J. biol. Chem. 266, 19626–19635 (1991).
Basu, M., Pace, J.L., Pinson, D.M. & Russell, S.W. A monoclonal antibody against the ligand binding site of the receptor for mouse interferon-γ. J. Interferon Res. 9, 551–562 (1989).
Nesbitt, M.N. & Francke, U. A system of nomenclature for band patterns of mouse chromosomes. Chromosoma 41, 145–158 (1973).
Steeg, C.M., Ellis, J. & Bernstein, A. Introduction of specific point mutations into RNA polymerase II by gene targeting in mouse embryonic stem cells: evidence for DNA mismatch repair mechanism. Proc. natn. Acad. Sci. U.S.A. 87, 4680–4684 (1990).
Valancius, V. & Smithies, O. Testing an “in-out” targeting procedure for making subtle genomic modifications in mouse embryonic stem cells. Molec. Cell Biol. 11, 1402–1408 (1991).
Thomas, K.R., Deng, C. & Capecchi, M.R. High-fidelity gene targeting in embryonic stem cells by using sequence replacement vectors. Molec. Cell Biol. 12, 2919–2923 (1992).
Roth, D. & Wilson, J. in Genetic recombination (eds Kucheriapati, R. & Smith, G.R.) 621–653 (American Society for Microbiology, Washington, 1988).
Mortensen, R.M., Conner, D.A., Chao, S., Geisterfer-Lowrance, A.A.T. & Seidman, J.G. Production of homozygous mutant ES cells with a single targeting construct. Molec. Cell Biol. 12, 2391–2395 (1992).
Jakobovits, A. et al. Analysis of homozygous mutant chimeric mice: deletion of the immunoglobulin heavy-chain joining region blocks B-cell development and antibody production. Proc. natn. Acad. Sci. U.S.A. 90, 2551–2555 (1993).
Germain, R.N. & Margulies, D.H. The biochemistry and cell biology of antigen processing and presentation. A. Rev. Immunol. 11, 403–450 (1993).
Trowsdale, J. et al. Sequences encoded in the class II region of the MHC related to the ‘ABC’ superfamily of transporters. Nature 348, 741–744 (1990).
Bao, S., King, N.J.C. & dos Remedios, C.G. Elevated MHC class I and II antigens in cultured human embryonic myoblasts following stimulation with γ-interferon. Immunol. Cell Biol. 68, 235–242 (1990).
Hooper, M., Hardy, K., Handyside, A., Hunter, S. & Monk, M. HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature 326, 292–295 (1987).
Robertson, E.J. in Teratocarcinomas and embryonic stem cells: a practical approach, (ed. Robertson, E.J.) 71–112 (IRL, Oxford, 1987).
Kuhn, R., Rajewsky, K. & Muller, W. Generation and analysis of interteukin-4 deficient mice. Science 254, 707–710 (1991).
Koller, B.H. & Smithies, O. Inactivating the β2-microglobulin locus in mouse embryonic stem cells by homologous recombination. Proc. natn. Acad. Sci. U.S.A. 86, 8932–8935 (1989).
Worton, R.G. & Duff, C., Karyotyping. Meth. Enzymol. 58, 322–344 (1979).
Verma, R.S. & Babu, A. in Human chromosomes: Manual of basic techniques 45–113 (Pergamon Press, New York. 1989).
Macpherson, I. & Montagnier, L. Agar suspension culture for the selective assay of cells transformed by polyoma virus. Virology 23, 291–294 (1964).
Rastinejad, F. & Blau, H.M. Genetic complementation reveals a novel regulatory role for 3′ untranslated regions in growth and differentiation. Cell 72, 903–917 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Arbonés, M., Austin, H., Capon, D. et al. Gene targeting in normal somatic cells: inactivation of the interferon–γ receptor in myoblasts. Nat Genet 6, 90–97 (1994). https://doi.org/10.1038/ng0194-90
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1038/ng0194-90
This article is cited by
-
Expression of reconstructive hFVIII in the hrDNA by using hrDNA targeting vector
Chinese Science Bulletin (2005)
-
In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides
Nature Medicine (1998)
-
Membrane-bound neomycin phosphotransferase confers drug-resistance in mammalian cells: A marker for high-efficiency targeting of genes encoding secreted and cell-surface proteins
Somatic Cell and Molecular Genetics (1994)


